| Name | Title | Contact Details |
|---|---|---|
Randall Deinhammer |
Senior R&D Manager | Profile |
Lone Dybdal Nilsson |
Vice President, Agriculture & Industrial Biosolutions R&D | Profile |
Mads Torry-Smith |
Head of Digitalization, Agriculture & Industrial Biosolutions R&D | Profile |
Kevin Cox |
R&D Director, Novozymes | Profile |
Kathryn Wiley |
CMO Manager - QES Americas | Profile |
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company`s founding team of MIT engineers and scientists are shaping the future of biologics delivery.
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, China; Boston and San Diego, USA.
Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida.
Columbus Children's Research Institute is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR).